Table 1.
Characteristics of 218 patients with HAP with regard to the adequacy of empirical antibiotic treatment
| Characteristics | Adequate treatment n = 128 | Inadequate treatment n = 90 | p |
|---|---|---|---|
| Age (years) |
61.84 ± 14.66 |
64.44 ± 13.49 |
0.189 |
| Sex (male) |
84 (65.6) |
58 (64.4) |
0.857 |
| Surgical unit |
24 (68.6) |
11 (31.4) |
0.269 |
| Underlying diseases |
|
|
|
| Diabetes mellitus |
26 (20.3) |
14 (15.6) |
0.474 |
| COPD |
32 (25.0) |
19 (21.1) |
0.613 |
| Chronic renal failure |
14 (10.9) |
10 (11.1) |
1.000 |
| Congestive heart failure |
15 (11.7) |
16 (17.8) |
0.287 |
| Cerebrovascular disease |
7 (5.5) |
10 (11.1) |
0.203 |
| Malignancy |
24 (18.8) |
22 (24.4) |
0.398 |
| Central venous catheterization |
37 (28.9) |
35 (38.9) |
0.123 |
| Urinary catheterization |
88 (68.8) |
66 (73.3) |
0.464 |
| Late-onset pneumonia |
78 (60.9) |
72 (80.0) |
0.003 |
| Acquisition of other site infection |
21 (16.4) |
20 (22.2) |
0.365 |
| Previous antibiotic usage |
42 (32.8) |
34 (37.8) |
0.449 |
| Culture proven pneumonia |
43 (33.6) |
51 (56.7) |
0.001 |
| MDR bacteria |
29 (22.7) |
38 (42.2) |
0.002 |
| Polymicrobial etiology |
1 (0.8) |
8 (8.9) |
0.004 |
| Length of stay before HAP |
7.09 ± 5.07 |
8.52 ± 5.26 |
0.003 |
| APACHE II score | 12.68 ± 5.79 | 14.63 ± 6.59 | 0.024 |